Vimarsana
Biggest News Aggregation in the World

Page 35 - User Fee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from User Fee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In User Fee Today - Breaking & Trending Today

Deadline Looms for FDA User Fee Legislation Renewal - Vimarsana News

Deadline Looms for FDA User Fee Legislation Renewal

The current authorization for FDA’s various human product user fee programs, excepting over-the-counter drug program that freshly created in 2020, will expire on September 30, end of federal government’s fiscal year, unless renewed by Congress before.

Indiana tax revenue far exceeds expectations in April, data show - Vimarsana News

Indiana tax revenue far exceeds expectations in April, data show

The state of Indiana is poised to end its 2022 budget year next month with an unprecedented $6 billion, or more, in its reserve accounts.

Federal Government Developments: TSCA, FIFRA, TRI, EPA Regulation - Vimarsana News

Federal Government Developments: TSCA, FIFRA, TRI, EPA Regulation

EPA announced two actions intended to safeguard communities from products containing per- and polyfluoroalkyl substances. EPA Publishes Receipt And Status Information For Certain New Chemicals For February 2022. Webinar On Biofuel PMNs: New Chemical Risk Assessment And Applications.

Federal Government Developments: TSCA, FIFRA, TRI, EPA Regulation - Vimarsana News

Federal Government Developments: TSCA, FIFRA, TRI, EPA Regulation

EPA announced two actions intended to safeguard communities from products containing per- and polyfluoroalkyl substances. EPA Publishes Receipt And Status Information For Certain New Chemicals For February 2022. Webinar On Biofuel PMNs: New Chemical Risk Assessment And Applications.

April 8th, 2022 Health Care Policy Update From Washington D.C. - Vimarsana News

April 8th, 2022 Health Care Policy Update From Washington D.C.

A bipartisan agreement on a $10 billion fully paid-for COVID-relief package was reached by the Senate, but the deal was sidelined. 2023 MA and Part D rate notice that MA plans will see an estimated 8.5% total average increase in payments next year.